H HEALIUS LTD
H
Closed
Sector Healthcare
1.64 -4.65
Overview
Share price change
24h
Min
1.64
Max
1.65
Income | -636M |
---|---|
Sales | 849M |
EPS | -0.024 |
Profit margin | -74.888 |
Recommendations | Sell |
---|---|
12 Months Forecast | -12.3 downside |
Market Cap | 58M 1.3B |
---|---|
Previous open | 6.29 |
Previous close | 1.64 |
HEALIUS LTD Chart
Related News
Peer Comparison
Price change
HEALIUS LTD Forecast
Price Target
By TipRanks
-12.3% downside
12 Months Forecast
Average 1.447 AUD -12.3%
High 1.8 AUD
Low 1 AUD
Based on 8 Wall Street analysts offering 12 month price targets forHEALIUS LTD - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About HEALIUS LTD
Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging, and Day Hospitals. The Pathology segment is a provider of pathology services. The Imaging segment is a provider of imaging and scanning services from standalone imaging sites, hospitals, and medical centers. The Day Hospitals segment is an operator of day hospitals. The Company has a network of pathology laboratories, diagnostic imaging centers, day hospitals, and In-Vitro Fertilization (IVF) clinics. It provides specialty diagnostic services to consumers and their referring practitioners, as well as supporting independent healthcare professionals in the delivery of care in its centers, day hospitals and fertility clinics. It also offers diagnostics, veterinary pathology services to veterinarians. The Company’s brands include QML Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, and Genomic Diagnostic.